We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.96%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAR icon
26
Interparfums
IPAR
$3.76B
$58M 0.59%
683,201
+202,207
+42% +$17.8M
ONTO icon
27
Onto Innovation
ONTO
$17B
$57.7M 0.59%
365,735
+58,259
+19% +$8.27M
ASO icon
28
Academy Sports + Outdoors
ASO
$2.71B
$57.6M 0.58%
1,151,937
-177,410
-13% -$8.8M
CIGI icon
29
Colliers International
CIGI
$5.35B
$56.3M 0.57%
383,228
+2,348
+0.6% +$353K
NPO icon
30
Enpro
NPO
$6.36B
$55.4M 0.56%
258,577
+18,143
+8% +$4.01M
HCKT icon
31
Hackett Group
HCKT
$285M
$51.9M 0.53%
2,642,287
+60,956
+2% +$1.16M
KD icon
32
Kyndryl
KD
$2.92B
$50.9M 0.52%
1,917,036
+186,620
+11% +$5.06M
VVV icon
33
Valvoline
VVV
$4.07B
$50.4M 0.51%
1,733,739
+431,687
+33% +$13.9M
BKU icon
34
Bankunited
BKU
$3.31B
$48.5M 0.49%
1,089,238
-160,373
-13% -$6.64M
MRX
35
Marex Group Limited Ordinary Shares
MRX
$5.13B
$48.4M 0.49%
1,260,709
-158,223
-11% -$5.38M
AGI icon
36
Alamos Gold
AGI
$15.5B
$47.3M 0.48%
1,224,091
-50,000
-4% -$1.74M
SSD icon
37
Simpson Manufacturing
SSD
$7.36B
$47M 0.48%
291,046
+30,418
+12% +$5.14M
IMAX icon
38
IMAX
IMAX
$2.79B
$46.7M 0.47%
1,264,397
-61,310
-5% -$2.14M
EXPO icon
39
Exponent
EXPO
$3.4B
$45.3M 0.46%
652,109
+276,889
+74% +$19.4M
COHU icon
40
Cohu
COHU
$2.32B
$44.6M 0.45%
1,918,424
+7,927
+0.4% +$182K
CPRX
41
DELISTED
Catalyst Pharmaceutical
CPRX
$44.6M 0.45%
1,910,767
-124,198
-6% -$2.77M
CECO icon
42
Ceco Environmental
CECO
$4.11B
$44.3M 0.45%
740,687
-84,473
-10% -$4.52M
HCSG icon
43
Healthcare Services Group
HCSG
$1.54B
$43.8M 0.44%
2,292,895
-572,102
-20% -$10.3M
LAZ icon
44
Lazard
LAZ
$4.23B
$43.5M 0.44%
896,328
+51,191
+6% +$2.55M
KBR icon
45
KBR
KBR
$4.79B
$43.4M 0.44%
1,080,201
+23,851
+2% +$1.02M
RBA icon
46
RB Global
RBA
$15.8B
$43.3M 0.44%
420,705
-23,820
-5% -$2.42M
KLIC icon
47
Kulicke & Soffa
KLIC
$4.28B
$42.9M 0.43%
941,022
-181,644
-16% -$7.67M
APAM icon
48
Artisan Partners
APAM
$3.12B
$42M 0.43%
1,031,344
-62,498
-6% -$2.67M
KFY icon
49
Korn Ferry
KFY
$4.49B
$42M 0.43%
635,858
-26,057
-4% -$1.75M
MHO icon
50
M/I Homes
MHO
$3.81B
$41.8M 0.42%
326,606
+16,445
+5% +$2.17M

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.